# Cell Responses to IFN-gamma

> **NCT01317017** · EARLY_PHASE1 · TERMINATED · sponsor: **Rockefeller University** · enrollment: 2 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** Actimmune

## Key facts

- **NCT ID:** NCT01317017
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Unable to isolate sufficient cells from the skin biopsy to perform study experiments.
- **Last updated:** 2013-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01317017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01317017, "Cell Responses to IFN-gamma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01317017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*